MEETING CANCELLED: Tumor Metabolism
Organizer(s): Joshua D. Rabinowitz, Marcia C. Haigis and David M. Sabatini Date: March 08 - 12, 2020
Location: Fairmont Banff Springs, Banff, AB, Canada
For important information on the coronavirus, please click here
The field of tumor metabolism is one of the oldest in cancer biology, dating back to the seminal work of Otto Warburg in the 1920s. Clinical importance of tumor metabolism is well validated by the successes both of FDG-PET imaging and of antimetabolites as chemotherapeutic agents. The recognition that oncogenes both promote the Warburg effect and activate anabolic pathways has provided impetus for revitalized examination of tumor metabolism. This conference brings together leaders in tumor metabolism to discuss ongoing efforts to understand and target metabolism of proliferating cancer cells and their support network. This conference will address key questions regarding the metabolism of proliferating cells, the unique metabolic features of tumors, and the associated opportunities for therapeutic intervention, including at the interface between metabolism and immunotherapy. A few key scientific questions that conference session will cover include (1) which features of cancer cell metabolism are shared across proliferating cells, and which are cancer specific? (2) what are the dependencies of tumors on host metabolism, and what is the impact of tumor metabolism on host cells, including invading lymphocytes? and (3) how does signaling drive metabolism, and how does metabolism impact signaling and cell fate decisions? Through discussion of these and other questions, the conference aims to generate new scientific ideas, promote collaborations, and enhance dissemination of the latest technologies and best practices for metabolic studies. As the premier venue sharing important unpublished data in the tumor metabolism field, this conference will help to accelerate scientific discovery and the development of new strategies to treat cancer.
Meeting has been cancelled. Please call our office if you have questions at 970-262-1230 or 1-800-253-0685.
We gratefully acknowledge additional support from these exhibitors at this conference:
We gratefully acknowledge additional support for this conference from:
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
We gratefully acknowledge the generous grant for this conference provided by:National Cancer Institute (NCI)
Grant No. 1R13CA247082-01
Funding for this conference was made possible (in part) by 1R13CA247082-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.